Absolute Lymphocyte Count: a Predictor of Positive Serum PCR for Trypanosoma cruzi in Patients with Chagas Disease Undergoing Heart Transplantation. [PDF]
Wolf PJW +6 more
europepmc +1 more source
Transcriptomic analysis of benznidazole-resistant Trypanosoma cruzi clone reveals nitroreductase I-independent resistance mechanisms. [PDF]
Mejía-Jaramillo AM +3 more
europepmc +1 more source
Aspects de la recherche en chimiothérapie antiparasitaire en Bolivie [PDF]
Deharo, Eric +4 more
core
Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias [PDF]
Almeida DR +28 more
core +1 more source
Heart transplants for patients with Chagas' heart disease [PDF]
ACOSTA A.M. +29 more
core +1 more source
[Erythema multiforme due to benzonidazole, in the treatment of Chagas' disease].
V, Amato Neto +2 more
openaire +1 more source
Análisis con Wavelets de alteraciones electrocardiográficas en pacientes Chagásticos crónicos [PDF]
Riveros Sanabria, Fernando
core
[Genetic diversity and Trypanosoma cruzi clone resistance to treatment with benzonidazole].
Max Jean, de Ornelas Toledo +1 more
openaire +1 more source
A doença de Chagas é uma enfermidade que afeta milhões de pessoas no mundo, principalmente em países em desenvolvimento. No Brasil, o único fármaco disponível para tratamento desta doença é o benzonidazol (BNZ). Atualmente o regime posológico para adultos consiste na administração deste fármaco na forma de comprimidos de liberação imediata de 100 mg em
openaire +1 more source
[Clinico-therapeutic trial with benzonidazole in Chagas' disease].
openaire +1 more source

